MLTX position history
The shares of Moonlake Immunotherapeutics (MLTX) that Avidity Partners Management LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q2: 400,000 shares, $20M, 0.71% of portfolio, New
- 2023 Q3: 777,172 shares, $44M, 1.8% of portfolio, Add +94.3%
- 2023 Q4: not held, Exit
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: not held
- 2025 Q2: 39,000 shares, $1.8M, 0.37% of portfolio, New
- 2025 Q3: not held, Exit
- 2025 Q4: not held
- 2026 Q1: 100,000 shares, $1.8M, 0.19% of portfolio, New
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|